Early Onset Venous and Arterial Thrombosis when Combining Osimertinib and Amivantamab in NSCLC: Instructive Cases and Literature Review
CURRENT PROBLEMS IN CANCER CASE REPORTS（2025）
Key words
NSCLC,EGFR,Amivantamab,Osimertinib,Venous Thromboembolism,Arterial Thrombosis,Thromboprophylaxis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined